3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management

Alessandro Armuzzi, Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O. Lindsay, Laurent Peyrin-Biroulet, Garret J. Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Gerassimos J. MantzarisFernando Rizzello, Stephan Vavricka, Paolo Gionchetti, Peter Bossuyt, Brankica Mijandrusic-Sincic, Thomas Douda, Jørn Brynskov, Torben Knudsen, Pia Manninen, Franck Carbonnel, Andreas Sturm, Ioannis Koutroubakis, Colm O'Morain, Anna Kohn, Ingrid Prytz Berset, Jaroslaw Kierkus, Edyta Zagorowicz, Mihai Mircea Diculescu, Adrian Goldis, Alexander Potapov, Francesc Casellas Jorda, Aykut Ferhat Celik, Peter Irving

Risultato della ricerca: Contributo in rivistaArticolo in rivista

853 Citazioni (Scopus)

Abstract

This paper is the first in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the methodology of the consensus process, and the classification, diagnosis and medical management of active and quiescent Crohn's disease. Surgical management as well as special situations including management of perianal Crohn's disease of this ECCO Consensus are covered in a subsequent second paper [Gionchetti et al JCC 2016].
Lingua originaleEnglish
pagine (da-a)3-25
Numero di pagine23
RivistaJournal of Crohn's and Colitis
Volume11
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Biologics
  • Crohn Disease
  • Crohn's disease
  • Endoscopy, Gastrointestinal
  • Evidence-Based Medicine
  • Fistulizing disease
  • Humans
  • Immunosuppressant
  • Intestines
  • Magnetic Resonance Imaging
  • Perianal disease
  • Recurrence
  • Remission Induction
  • Steroids
  • Strictureplasty
  • Thiopurine
  • Tomography, X-Ray Computed
  • Treatment
  • Vedolizumab

Fingerprint Entra nei temi di ricerca di '3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management'. Insieme formano una fingerprint unica.

Cita questo